Ascend Gene & Cell Therapies
UKEntry
2023
Hold
3yr
Status
Active
Who owns Ascend Gene & Cell Therapies?
Ascend Gene & Cell Therapies is a British Biotech company, currently owned by Abingworth since 2023.
Hand-verified · updated 2026-05-21
Open JSON · CC-BY
More from Abingworth Bioventures 8
Other portfolio companies in the same fund.
US
More PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Ascend Gene & Cell Therapies?
Ascend Gene & Cell Therapies is currently owned by Abingworth, through Abingworth Bioventures 8, since 2023.
When did Abingworth acquire Ascend Gene & Cell Therapies?
Abingworth acquired Ascend Gene & Cell Therapies in 2023.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue